Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Accounts Payables: 2012-2024

Historic Accounts Payables for Veracyte (VCYT) over the last 13 years, with Dec 2024 value amounting to $8.6 million.

  • Veracyte's Accounts Payables fell 43.03% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 43.03%. This contributed to the annual value of $8.6 million for FY2024, which is 33.29% down from last year.
  • Per Veracyte's latest filing, its Accounts Payables stood at $8.6 million for FY2024, which was down 33.29% from $12.9 million recorded in FY2023.
  • In the past 5 years, Veracyte's Accounts Payables ranged from a high of $12.9 million in FY2023 and a low of $3.1 million during FY2020.
  • Moreover, its 3-year median value for Accounts Payables was $11.9 million (2022), whereas its average is $11.2 million.
  • In the last 5 years, Veracyte's Accounts Payables skyrocketed by 296.66% in 2021 and then plummeted by 33.29% in 2024.
  • Over the past 5 years, Veracyte's Accounts Payables (Yearly) stood at $3.1 million in 2020, then surged by 296.66% to $12.4 million in 2021, then decreased by 3.63% to $11.9 million in 2022, then increased by 8.66% to $12.9 million in 2023, then plummeted by 33.29% to $8.6 million in 2024.